Quantcast

Industry news that matters to you.  Learn more

Metabolon Awarded US Patent for Metabolic Biomarkers of Efficacy of Peroxisome Proliferator Activated Receptor (PPAR) Affecting Drugs

Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announced today the grant of US Patent 7,807,138 entitled “Biomarkers of Metabolic Responses to Hepatic Drugs”. The USPTO awarded the patent to Metabolon on October 5, 2010. This is the 13th patent issued to Metabolon and the second in its portfolio of biomarker patents.

New Clue to Diabetic Heart Disease Discovered

Scientists from King’s College London have identified a molecule that could help predict type 2 diabetes and identify diabetics that are most vulnerable to heart and circulatory disease.